Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) <i>versus</i> CHOP in newly diagnosed peripheral T-cell lymphoma patients
Yuanyuan Sun(First Affiliated Hospital of Zhengzhou University), Mingzhi Zhang(Chinese Academy of Sciences), Zhaoming Li(First Affiliated Hospital of Zhengzhou University), Xiaolong Wu(First Affiliated Hospital of Zhengzhou University), Xin Li(China Medical University), Xinhua Wang(Zhengzhou University), Lei Zhang(First Affiliated Hospital of Zhengzhou University), Jingjing Wu(Beijing Tian Tan Hospital), Tian Li(Xuzhou Central Hospital), Zhenchang Sun(First Affiliated Hospital of Zhengzhou University), Hui Yu(First Affiliated Hospital of Zhengzhou University), Xiaorui Fu(First Affiliated Hospital of Zhengzhou University), Yu Chang(Jilin University), Xudong Zhang(First Affiliated Hospital of Zhengzhou University), Feifei Nan(First Affiliated Hospital of Zhengzhou University), Ling Li(First Affiliated Hospital of Zhengzhou University), Jiaqin Yan(First Affiliated Hospital of Zhengzhou University), Zhi‐Yuan Zhou(Tsinghua University)
Cited by 19
Related Papers
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
|Cancer Cell|2018|251
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts
|Nature Communications|2022|247
The genome of Mesobuthus martensii reveals a unique adaptation model of arthropods
|Nature Communications|2013|233